9-Benzyl-2,4-dioxo-3,9-diazaspiro[5.5]undecane-1,5-dicarbonitrile, 97%, 1g

1-(4-Methoxyphenyl)imidazole, 98.0%, 100mg

trans-2-hexen-1-ol, mínimo 95 %, 5 ml, envase de vidrio

3-(1-methyl-1H-pyrazol-3-yl)propanoic acid, 95.0%, 500mg

3,4,5-Trimethoxybenzaldehyde, 95.0%, 500g

N-(tert-Butoxycarbonyl)-4-chloro-L-phenylalanine>98.0%(HPLC)(T)1g

1-AMINO-2-CHLORONAPHTHALENE, 95%, 5g

3-(2,2-Dichloroethenyl)-N-(1-hydroxy-2-oxo-2-phenylethyl)-2,2-dimethyl-cyclopropanecarboxamide, 25mg

2-((((8R,9S,13S,14S,E)-3-Hydroxy-13-methyl-6,7,8,9,11,12,13,14,15,16-decahydro-17H-cyclopenta[a]phenanthren-17-ylidene)amino)oxy)acetic acid, 98%, 1g

2',4'-BIS(BENZYLOXY)ACETOPHENONE, 97.0%, 1g

Methyl 1-(methylamino)cyclobutane-1-carboxylate hydrochloride, 1g

Dicyclohexylamine (R)-2-((tert-butoxycarbonyl)amino)butanoate, 95.0%, 1g

(3-(Trifluoromethoxy)phenyl)hydrazinehydrochloride, 95.0%, 1g